The Movement Disorders Fellowship at the University of Utah offers broad clinical exposure to movement disorders, including botulinum toxin injection and DBS programming.
Trainees have exposure to an active clinical trials program and are offered the opportunity to complete a Masters in Clinical Investigation. We accept one fellow annually for a one-year fellowship, with an optional second year.
- Fellows can function as sub-investigators for movement disorders clinical trials and receive mentoring in the development and execution of individual research projects.
- Opportunities are available for collaborative projects in traditional movement disorders clinical trials, neurogenetics, autoimmune movement disorders, autonomic function, and neuroimaging.
- Close collaboration with the Bioengineering Program, Scientific Computing and Imaging Institute, and Department of Neurosurgery is available.
- Matriculation for a Master of Science in Clinical Investigation is available.
Fellows will participate in the following:
- Monthly meetings: Video Case Conference, DBS, Research, Literature Review, and Education.
- Optional participation in the Movement Disorder lecture series for residents and medical students.
Fellows will be exposed to the following:
- A large patient volume in a broad clinical setting.
- Neuromodulation clinic: surgery case volume of one per week, programming daily, and exposure to all current devices.
- Botulinum toxin injection: occurring daily.
- Centers of Excellence: the Huntington’s Disease Society of America (HDSA) Center of Excellence and the Tourette Association of America (TAA) Center of Excellence.
- Subspecialty clinics: ataxia, neurogenetics, autoimmune movement disorders, and cognitive disorders.
- Must be BC/BE neurologists or individuals who have completed their ACGME-accredited neurology residency training by the fellowship start date.
- Must be US citizen, permanent resident, or hold a J-1 clinical visa.